AstraZeneca Pharma India board to meet for Q3, half-year results

AstraZeneca Pharma India Limited has scheduled a board of directors meeting for Friday, November 7, 2025. The primary agenda for this meeting is to consider and approve the unaudited financial results for the quarter and half-year period ending September 30, 2025.

In conjunction with the upcoming board meeting, the 'Trading Window' for all designated persons remains closed. This restriction commenced on September 16, 2025, and will continue until November 9, 2025, inclusive of both dates. This closure is in adherence to the company's Code of Conduct for Prevention of Insider Trading, framed under the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015.

The announcement was made on October 27, 2025, by Manasa. R, the company secretary. The communication was addressed to both the National Stock Exchange of India Ltd. and BSE Limited.